The Food and Drug Administration said Tuesday that an experimental psychiatric drug, Saphris, appeared to be safe and effective, reported Reuters.Reuters reported that a panel of outside psychiatrists would examine and vote on Thursday whether or not the FDA should approve the drug; however, the FDA is not required to make its decision based on the vote.Schering-Plough Corp. conducted four
No comments:
Post a Comment